These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29958953)

  • 1. Deciphering the role of IspD (2‑C‑methyl‑D‑erythritol 4‑phosphate cytidyltransferase) enzyme as a potential therapeutic drug target against Plasmodium vivax.
    Saggu GS; Garg S; Pala ZR; Kochar SK; Saxena V
    Gene; 2018 Oct; 675():240-253. PubMed ID: 29958953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Mechanism of Action of Antimalarial Benzoisothiazolones: Species-Selective Inhibitors of the Plasmodium spp. MEP Pathway enzyme, IspD.
    Price KE; Armstrong CM; Imlay LS; Hodge DM; Pidathala C; Roberts NJ; Park J; Mikati M; Sharma R; Lawrenson AS; Tolia NH; Berry NG; O'Neill PM; John AR
    Sci Rep; 2016 Nov; 6():36777. PubMed ID: 27857147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological Studies and Target Engagement of the 2- C-Methyl-d-Erythritol 4-Phosphate Cytidylyltransferase (IspD)-Targeting Antimalarial Agent (1 R,3 S)-MMV008138 and Analogs.
    Ghavami M; Merino EF; Yao ZK; Elahi R; Simpson ME; Fernández-Murga ML; Butler JH; Casasanta MA; Krai PM; Totrov MM; Slade DJ; Carlier PR; Cassera MB
    ACS Infect Dis; 2018 Apr; 4(4):549-559. PubMed ID: 29072835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural modeling identifies Plasmodium vivax 4-diphosphocytidyl-2C-methyl-d-erythritol kinase (IspE) as a plausible new antimalarial drug target.
    Kadian K; Vijay S; Gupta Y; Rawal R; Singh J; Anvikar A; Pande V; Sharma A
    Parasitol Int; 2018 Aug; 67(4):375-385. PubMed ID: 29550587
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Imlay LS; Armstrong CM; Masters MC; Li T; Price KE; Edwards RL; Mann KM; Li LX; Stallings CL; Berry NG; O'Neill PM; Odom AR
    ACS Infect Dis; 2015 Apr; 1(4):157-167. PubMed ID: 26783558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (IspG) from Plasmodium vivax and it's potential as an antimalarial drug target.
    Saggu GS; Garg S; Pala ZR; Yadav SK; Kochar SK; Kochar DK; Saxena V
    Int J Biol Macromol; 2017 Mar; 96():466-473. PubMed ID: 28007455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis of isoprenoids: characterization of a functionally active recombinant 2-C-methyl-D-erythritol 4-phosphate cytidyltransferase (IspD) from Mycobacterium tuberculosis H37Rv.
    Shi W; Feng J; Zhang M; Lai X; Xu S; Zhang X; Wang H
    J Biochem Mol Biol; 2007 Nov; 40(6):911-20. PubMed ID: 18047786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the Mycobacterium tuberculosis 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase: potential for drug development.
    Eoh H; Brown AC; Buetow L; Hunter WN; Parish T; Kaur D; Brennan PJ; Crick DC
    J Bacteriol; 2007 Dec; 189(24):8922-7. PubMed ID: 17921290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A structural and functional study on the 2-C-methyl-d-erythritol-4-phosphate cytidyltransferase (IspD) from Bacillus subtilis.
    Jin Y; Liu Z; Li Y; Liu W; Tao Y; Wang G
    Sci Rep; 2016 Nov; 6():36379. PubMed ID: 27821871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apicoplast Metabolism: Parasite's Achilles' Heel.
    Kadian K; Gupta Y; Singh HV; Kempaiah P; Rawat M
    Curr Top Med Chem; 2018; 18(22):1987-1997. PubMed ID: 30499407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homology modeling of Mycobacterium tuberculosis 2C-methyl-D-erythritol-4-phosphate cytidylyltransferase, the third enzyme in the MEP pathway for isoprenoid biosynthesis.
    Obiol-Pardo C; Cordero A; Rubio-Martinez J; Imperial S
    J Mol Model; 2010 Jun; 16(6):1061-73. PubMed ID: 19916033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the IspD Enzyme in the MEP Pathway: Identification of a Novel Fragment Class.
    Diamanti E; Hamed MM; Lacour A; Bravo P; Illarionov B; Fischer M; Rottmann M; Witschel M; Hirsch AKH
    ChemMedChem; 2022 Mar; 17(5):e202100679. PubMed ID: 34918860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering structure, function and mechanism of Plasmodium IspD homologs from their evolutionary imprints.
    Chellapandi P; Prathiviraj R; Prisilla A
    J Comput Aided Mol Des; 2019 Apr; 33(4):419-436. PubMed ID: 30783866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Insight into Isoprenoids Biosynthesis Process and Future Prospects for Drug Designing in Plasmodium.
    Saggu GS; Pala ZR; Garg S; Saxena V
    Front Microbiol; 2016; 7():1421. PubMed ID: 27679614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylerythritol phosphate pathway to isoprenoids: kinetic modeling and in silico enzyme inhibitions in Plasmodium falciparum.
    Singh VK; Ghosh I
    FEBS Lett; 2013 Sep; 587(17):2806-17. PubMed ID: 23816706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and functional characterization of 2-C-methyl-D-erythritol 4-phosphate cytidyltransferase (GbMECT) gene from Ginkgo biloba.
    Kim SM; Kuzuyama T; Chang YJ; Kwon HJ; Kim SU
    Phytochemistry; 2006 Jul; 67(14):1435-41. PubMed ID: 16828818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Evaluation of Fluoroalkyl Phosphonyl Analogues of 2- C-Methylerythritol Phosphate as Substrates and Inhibitors of IspD from Human Pathogens.
    Bartee D; Wheadon MJ; Freel Meyers CL
    J Org Chem; 2018 Sep; 83(17):9580-9591. PubMed ID: 29870251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional studies of mycobacterial IspD enzymes.
    Björkelid C; Bergfors T; Henriksson LM; Stern AL; Unge T; Mowbray SL; Jones TA
    Acta Crystallogr D Biol Crystallogr; 2011 May; 67(Pt 5):403-14. PubMed ID: 21543842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chemical rescue screen identifies a Plasmodium falciparum apicoplast inhibitor targeting MEP isoprenoid precursor biosynthesis.
    Wu W; Herrera Z; Ebert D; Baska K; Cho SH; DeRisi JL; Yeh E
    Antimicrob Agents Chemother; 2015 Jan; 59(1):356-64. PubMed ID: 25367906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and structural characterization of PvSERA4: potential implication as therapeutic target for Plasmodium vivax malaria.
    Rahul CN; Shiva Krishna K; Pawar AP; Bai M; Kumar V; Phadke S; Rajesh V
    J Biomol Struct Dyn; 2014 Apr; 32(4):580-90. PubMed ID: 23582016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.